期刊文献+

美多巴停用致恶性综合征2例报道 被引量:2

Madopar withdrawal induced malignant syndrome:report of two cases
下载PDF
导出
摘要 目的探讨恶性综合征的临床表现,了解导致恶性综合征的诱因。方法报道2例患者因停用美多巴导致的恶性综合征,复习相关文献进行讨论。结果 2例患者均为长时间服用美多巴突然停用导致的恶性综合征,而急性低钠血症和感染会诱发和促进恶性综合征的发生。结论恶性综合征是临床较重的急症,临床医师应提高对该病的认识。 Objective To investigate the Clinical features and other risk factors for malignant syndrome(MS). Methods we reported two patients with MS who suddenly stop their madopar treatment and review of the previous literature. Results 2 patients with MS were taking madopar for a long time because of abrupt discontinuation madopar,and acute hyponatremia and infection can induce and worsen MS. Conclusion MS is a clinical heavier emergency. Clinicians should improve the understanding of early diagnosis of the MS.
出处 《安徽医药》 CAS 2014年第5期928-929,共2页 Anhui Medical and Pharmaceutical Journal
基金 国家自然科学基金资助项目(No 81301095) 安徽省高校省级自然科学基金项(No KJ2011Z198)
关键词 美多巴 恶性综合征 帕金森病 madopar malignant syndrome parkinson's disease
  • 相关文献

参考文献11

  • 1汪洋.55例抗精神病药物的不良反应报告分析[J].安徽医药,2010,14(3):358-360. 被引量:8
  • 2方馨怡,蒋幸衍,徐清.奥氮平引起恶性综合征1例[J].临床精神医学杂志,2011,21(6):370-370. 被引量:2
  • 3陈国平,徐丽华,赵国平,蒋正华,杨健身.奎硫平与丙戊酸钠联用致恶性综合征一例[J].中华精神科杂志,2012,45(4):195-195. 被引量:4
  • 4Ghaffari N, Dossett E, Lee RH, et al. Antipsychotics leading to neuroleptic malignant syndrome in pregnancy [ J 1. Obstet Gyne- col,2012,119(2 Pt 2) :436 -438.
  • 5Ishioka M,Yasui-Furukori N, Hashimoto K, et al. Neuroleptic ma- lignant syndrome induced by lamotrigine [ J ]. Clin Neuropharma- col,2013,36(4) :131 - 132.
  • 6Szota A,Oglodek E, Araszkiewicz A. Fever development in neuro- leptic malignant syndrome during treatment with olanzapine and clozapine[ J]. Pharmacol Rep ,2013,65 ( 2 ) :279 - 287.
  • 7Levenson JL. Neuroleptie malignant syndrome [ J ]. Am J Psychia- try,1985,142(10) :1137 -1145.
  • 8董宁,陈秋惠,张颖,张医芝.帕金森病相关恶性综合征的研究进展[J].中国老年学杂志,2013,33(14):3527-3528. 被引量:17
  • 9Hashimoto T, Tokuda T, Hanyu N, et al. Withdrawal of levodopa and other risk factors for malignant syndrome in Parkinson disease [ J 3. Parkinsonism Relat Disord,2003,9 ( Suppl 1 ) : s25 - s30.
  • 10Lenhard T, Ktilkens S, Schwab S. Cerebral salt -wasting syndrome in a patient with neuroleptic malignant syndrome[ J ]. Arch Neu- rol,2007,64( 1 ) : 122 - 125.

二级参考文献25

  • 1祝英禄.奎硫平的不良反应[J].山东精神医学,2006,19(2):150-153. 被引量:4
  • 2钟涌.精神分裂症患者长期应用氯氮平的血糖状况分析[J].中国临床保健杂志,2007,10(3):293-294. 被引量:4
  • 3刘晓鸿,张明生.300例药品不良反应报告分析[J].安徽医药,2007,11(7):663-664. 被引量:3
  • 4汪洋.利培酮致不良反应概述[J].中国药业,2007,16(16):57-59. 被引量:10
  • 5Torn M,Matsuda 0,Makiguch K,ef al. Neuroleptic, malignant syndromelike state following a withdrawal of antiparkinsonian drugs[ J]. J NervMent Dis, 1981 ;169(5) :324-7.
  • 6Harada T,Mitsuoka K, Kumagai R, et al. Clinical features of maligantsyndrome in Parkinson's disease and related neurological disorders[J].Parkinsonism Relat Disord,2003 ;9( suppl 1 ) :15-23.
  • 7Di Rosa AE,Morgante L,Coraci MA,et al. Functional hyperthermia due tocentral dopaminergic impairment[ J3. Funct Neurol,1988;3(2) :211 -5.
  • 8Shimada J.Sakakibara R,Uchiyama T,et al. Intestinal pseudo-obstructionand neuroleptic malignant syndrome in a chronically constipated parkin-sonian patient[J]. Eur J Neurol,2006; 13{3) :306-7.
  • 9Figa-Talamanca L, Gualandi C, Di Meo L, et al. Hyperthermia after dis-continuance of levodopa and bromocriptine therapy : impaired dopaminereceptors a possible cause[J]. Neuroloy, 1985 ;35 (2) :258-61.
  • 10KomhuberJ, Weller M. Neuroleptic malignant syndrome ( J ] . Curr OpinNeurol,1994;7(4) :353-7.

共引文献26

同被引文献17

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部